{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:56:51Z","timestamp":1780372611864,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.semarthrit.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T17:53:00Z","timestamp":1521395580000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis"],"prefix":"10.1016","volume":"48","author":[{"given":"Roxanne","family":"Cooksey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7417-2858","authenticated-orcid":false,"given":"Sinead","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola Fernandez","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-8609","authenticated-orcid":false,"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2018.03.005_bib1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/annrheumdis-2014-206617","article-title":"Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation?","volume":"74","author":"Kristensen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib3","first-page":"435","article-title":"Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis","volume":"32","author":"Dessein","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib4","doi-asserted-by":"crossref","first-page":"e6242","DOI":"10.1371\/journal.pone.0006242","article-title":"Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis","volume":"4","author":"Graf","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2018.03.005_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/09546634.2014.983039","article-title":"Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study","volume":"26","author":"Belinchon","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jdv.12742","article-title":"Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink","volume":"29","author":"Edson-Heredia","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/18715281113126660061","article-title":"Risk factors for cardiovascular disease in psoriasis: relation to inflammation assessed by the severity and duration of illness","volume":"12","author":"Calamita","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/1346-8138.12267","article-title":"Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease","volume":"40","author":"Torres","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","article-title":"Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review","volume":"72","author":"Jamnitski","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib16","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3899\/jrheum.100034","article-title":"Mortality in psoriatic arthritis\u2014a single-center study from the UK","volume":"37","author":"Buckley","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib17","first-page":"1354","article-title":"Incidence and prevalence of psoriatic arthritis: a systematic review","volume":"35","author":"Alamanos","year":"2008","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2018.03.005_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib19","first-page":"19","article-title":"Cardiovascular risk in psoriatic arthritis\u2014a cross-sectional study","volume":"9","author":"Popescu","year":"2014","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/acr.20363","article-title":"Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls\u2014the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/acr.22144","article-title":"Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis","volume":"66","author":"Lin","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib23","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/acr.22536","article-title":"Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study","volume":"67","author":"Ernste","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib25","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/jid.2015.87","article-title":"Psoriasis and the risk of major cardiovascular events: cohort study using the Clinical Practice Research Datalink","volume":"135","author":"Parisi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study","volume":"130","author":"Dregan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-016-1077-z","article-title":"Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis","volume":"18","author":"Meissner","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1472-6947-12-24","article-title":"HERALD (health economics using routine anonymised linked data)","volume":"12","author":"Husain","year":"2012","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1472-6963-9-157","article-title":"The SAIL Databank: building a national architecture for e-health research and evaluation","volume":"9","author":"Ford","year":"2009","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib31","doi-asserted-by":"crossref","first-page":"g2384","DOI":"10.1136\/bmj.g2384","article-title":"The Secure Anonymised Information Linkage (SAIL) system in Wales has privacy protection at its heart","volume":"348","author":"Lyons","year":"2014","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib33","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib34","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/rheumatology\/ket239","article-title":"Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment","volume":"52","author":"Paramarta","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2010.01.050","article-title":"Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan","volume":"64","author":"Lin","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2018.03.005_bib36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2014-206824","article-title":"On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trondelag Health Study","volume":"75","author":"Gulati","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","article-title":"Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey","volume":"70","author":"Lebwohl","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/PPA.S121838","article-title":"Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments","volume":"11","author":"Eliasson","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib40","first-page":"668","article-title":"The Swedish early psoriatic arthritis register\u20142-year followup: a comparison with early rheumatoid arthritis","volume":"35","author":"Lindqvist","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jbspin.2013.07.008","article-title":"Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"81","author":"Rosales Alexander","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/met.2013.0039","article-title":"Increased prevalence of metabolic syndrome in patients with psoriatic arthritis","volume":"12","author":"Pehlevan","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2133.2011.10774.x","article-title":"Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study","volume":"166","author":"Li","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib44","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib45","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2018.03.005_bib46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/rheumatology\/41.7.793","article-title":"The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century","volume":"41","author":"Symmons","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 2","key":"10.1016\/j.semarthrit.2018.03.005_bib47","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib48","first-page":"602","article-title":"Validity of The Health Improvement Network (THIN) for the study of psoriasis","volume":"164","author":"Seminara","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib49","series-title":"Coronary Heart Disease Statistics","author":"Townsend","year":"2012"},{"key":"10.1016\/j.semarthrit.2018.03.005_bib50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00128071-200304070-00001","article-title":"Prevalence of joint disease in patients with psoriasis: implications for therapy","volume":"4","author":"Zachariae","year":"2003","journal-title":"Am J Clin Dermatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217306212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217306212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T21:21:55Z","timestamp":1751491315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017217306212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0049017217306212"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.03.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}